sb 203580 has been researched along with pf 4800567 in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (pf 4800567) | Trials (pf 4800567) | Recent Studies (post-2010) (pf 4800567) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 10 | 0 | 9 |
| Protein | Taxonomy | sb 203580 (IC50) | pf 4800567 (IC50) |
|---|---|---|---|
| Chain A, Casein kinase I isoform delta | Homo sapiens (human) | 0.3715 | |
| Chain A, Casein kinase I isoform epsilon | Homo sapiens (human) | 0.3715 | |
| Gonadotropin-releasing hormone receptor | Homo sapiens (human) | 0.032 | |
| Casein kinase I isoform delta | Homo sapiens (human) | 0.5413 | |
| Casein kinase I isoform epsilon | Homo sapiens (human) | 0.032 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Munoz, L | 1 |
1 review(s) available for sb 203580 and pf 4800567
| Article | Year |
|---|---|
Non-kinase targets of protein kinase inhibitors.
Topics: Animals; Drug Design; Drug Evaluation, Preclinical; Humans; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Kinases | 2017 |